Rocket Lab USA Inc. (Rocket Lab (RKLB)) shares took a nosedive on Thursday, falling more than 12% as the broader space sector got caught in a downdraft fueled by debt dilution fears. The selloff came as Piper Sandler initiated coverage on the company with a Neutral rating and an $83 price target, adding a layer of analyst caution to the mix.
The broader market wasn't exactly helping either—the Nasdaq was down 0.83% and the S&P 500 slipped 0.24%—but the real pain was concentrated in space stocks. The culprit? AST SpaceMobile Inc. (AST SpaceMobile (ASTS)) announced the pricing of a $1 billion proposed public offering of Convertible Senior Notes, and investors immediately started worrying about dilution. That fear spread like wildfire, dragging down the Procure Space ETF (UFO) and the WisdomTree Space Economy Fund (WSPC) by 2.36% each.
Archimedes Engine Milestone
This decline comes on the heels of some genuinely good news for Rocket Lab. Earlier this week, the company completed a hot-fire test of its Archimedes Vacuum engine, which it called "critical preparation for Neutron’s first flight." The Neutron rocket is still on track for its debut launch in late 2026. So the stock's drop isn't about any company-specific failure—it's more about the tide going out on the whole sector.
Iridium Deal and Market Rivalry
Rocket Lab is also pushing ahead with its expansion strategy, including a proposed $8 billion acquisition of Iridium Communications Inc. (Iridium (IRDM)). According to Reuters, the deal is designed to align Rocket Lab with the vertically integrated model of SpaceX—basically, owning more of the supply chain and reducing reliance on third parties. It's a bold move that could pay off big if it works, but it also adds complexity and risk in the near term.
Technical Analysis
From a chart perspective, things look a bit rough right now. Rocket Lab stock is trading 21.8% below its 20-day simple moving average (SMA) of $89.32 and 34.6% below its 50-day SMA of $106.75. That kind of distance from those averages usually means any rally attempts are going to be sold into until the price can reclaim at least one of those levels. It's also 9.7% below the 200-day SMA of $77.33, so that longer-term trend line is now acting like a ceiling overhead.
The bearish 20-day/50-day moving-average relationship is a warning sign, but it's worth noting that the 50-day SMA is still above the 200-day SMA—a reminder that the bigger-picture trend only recently started to weaken. Key levels to watch are pretty tight:
- Key Resistance: $78.50
- Key Support: $64
RKLB Price Action: Rocket Lab shares were down 12.05% at $67.02 at the time of publication on Thursday, according to market data.
